Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Mathilde Latreille"'
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 11, Pp 2674-2677 (2017)
An inactivated split-virion trivalent influenza vaccine (IIV3; Vaxigrip®, Sanofi Pasteur) has been available globally since 1968. Here, we describe the results of an open-label, post-licensure trial (EudraCT no. 2014-005078-12) to confirm the immuno
Externí odkaz:
https://doaj.org/article/6cf57ac016944973ad180080db37e806
Autor:
Antoine Tarral, Lionel Hovsepian, Thierry Duvauchelle, Yves Donazzolo, Mathilde Latreille, Mathieu Felices, Virginie Gualano, Sophie Delhomme, Olaf Valverde Mordt, Severine Blesson, Pascal Voiriot, Nathalie Strub-Wourgaft
Publikováno v:
Clinical Pharmacokinetics. 62:481-491
Autor:
Xavier Pelletier, Mathilde Latreille-Barbier, Alvin Ibarra, Arthur C. Ouwehand, Yves Donazzolo
Publikováno v:
Gut Microbes
Bifidobacterium animalis subsp. lactis HN019 (HN019) ameliorates chronic idiopathic constipation. Our aim was to determine the efficacy and safety of 28-day supplementation with 1 × 109 or 1 × 1010 CFU of HN019/day for constipation. A total of 228
Publikováno v:
Human Vaccines & Immunotherapeutics
An inactivated split-virion trivalent influenza vaccine (IIV3; Vaxigrip®, Sanofi Pasteur) has been available globally since 1968. Here, we describe the results of an open-label, post-licensure trial (EudraCT no. 2014-005078-12) to confirm the immuno
Autor:
Mathilde Latreille-Barbier, Alvin Ibarra, Arthur C. Ouwehand, Xavier Pelletier, Yves Donazzolo
Publikováno v:
American Journal of Gastroenterology. 112:S243
Publikováno v:
Journal of cardiovascular pharmacology. 64(5)
The effects of the antidepressant agomelatine up to a supratherapeutic dose (400 mg, single dose) on the QT corrected (QTc) interval were assessed in a randomized, double-blind, placebo- and positive-controlled, crossover thorough QT/QTc study in you
Autor:
Magali Michaud, Marcel Culcasi, Sylvia Pietri, Yves Donazzolo, Sophie Le Lamer, Jean Afxantidis, Hidayat Rahmouni, Stéphanie Paradis, Didier Morin, Corinne Chaimbault, Patrick Berna, Mathilde Latreille, Rebacca M Pruss, Sophie Schaller, Jean-Louis Abitbol, Alain Berdeaux
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, BioMed Central, 2014, 12 (1), pp.38. ⟨10.1186/1479-5876-12-38⟩
Journal of Translational Medicine, 2014, 12 (1), pp.38. ⟨10.1186/1479-5876-12-38⟩
Journal of Translational Medicine, BioMed Central, 2014, 12 (1), pp.38. ⟨10.1186/1479-5876-12-38⟩
Journal of Translational Medicine, 2014, 12 (1), pp.38. ⟨10.1186/1479-5876-12-38⟩
International audience; BACKGROUND: Although reperfusion injury has been shown to be responsible for cardiomyocytes death after an acute myocardial infarction, there is currently no drug on the market that reduces this type of injury. TRO40303 is a n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e29fba0c6f82477024412f6a88a93912
https://www.hal.inserm.fr/inserm-00946700
https://www.hal.inserm.fr/inserm-00946700
Autor:
Herve Abry, Philippe Emile Fernand Laurent, Celine Feger, Yves Donazzolo, Mathilde Latreille, Florence Schwarzenbach, Joël Cotten, Cecile Berteau, Julie Berube
Publikováno v:
Patient preference and adherence
Cecile Berteau1, Florence Schwarzenbach1, Yves Donazzolo2, Mathilde Latreille2, Julie Berube3, Herve Abry1, Joël Cotten1, Celine Feger1, Philippe E Laurent11BD Medical Pharmaceutical Systems, Le-Pont-de-Claix, 2Eurofins Optimed Clinical Research, Gi